0

Zopolrestat

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP110703941
CAS110703-94-1
Structure
MDL NumberMFCD00865476
Molecular Weight419.38
InChI KeyBCSVCWVQNOXFGL-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥20 mg/mL
Assay≥98% (HPLC)
Coloroff-white to light brown
Formpowder
Size10MG, 50MG
Storage Conditions2-8°C
1

Attenuation of Ischemia Induced Increases in Sodium and Calcium by the Aldose Reductase Inhibitor Zopolrestat

R Ramasamy, H Liu, P J Oates, S Schaefer

Cardiovasc Res. 1999 Apr;42(1):130-9.

PMID: 10435004

1

Pharmacokinetics of the Aldose Reductase Inhibitor, Zopolrestat, in Humans

P B Inskeep, R A Ronfeld, M J Peterson, N Gerber

J Clin Pharmacol. 1994 Jul;34(7):760-6.

PMID: 7929871

1

Pharmacokinetics of Zopolrestat, a Carboxylic Acid Aldose Reductase Inhibitor, in Normal and Diabetic Rats

P B Inskeep, A E Reed, R A Ronfeld

Pharm Res. 1991 Dec;8(12):1511-5.

PMID: 1808615

1

Zopolrestat Induced Suicidal Death of Human Erythrocytes

Ghada Bouguerra, Rosi Bissinger, Salem Abbès, Florian Lang

Cell Physiol Biochem. 2015;37(4):1537-46.

PMID: 26512879

1

Zopolrestat Prevention of Proteinuria, Albuminuria and Cataractogenesis in Diabetes Mellitus

A Beyer-Mears, K Mistry, F P Diecke, E Cruz

Pharmacology. 1996 May;52(5):292-302.

PMID: 8807673

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode